Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaint Gobain Or Regulatory News (COD)

  • There is currently no data for COD

Disposal

29 Sep 2021 18:13

RNS Number : 4520N
Compagnie de Saint-Gobain
29 September 2021
 

PRESS RELEASE

 

 

September 29, 2021

 

 

SAINT-GOBAIN COMPLETES ITS ACQUISITION OF CHRYSO

 

 

In line with its May 20, 2021 announcement, Saint-Gobain has today completed its acquisition of Chryso, a leading global player on the construction chemicals market.

 

Chryso provides comprehensive additives solutions for sustainable construction, helping to significantly reduce the carbon footprint of concrete. The company employs about 1,300 employees and generates approximately €400 million in annual sales and around €85 million in EBITDA.

 

The enterprise value of €1,020 million represents a multiple of 12.0x Chryso's last 12 months EBITDA of €85 million and a multiple of 7.6x post run-rate synergies of €50 million in year 5.

 

Chryso joins the businesses serving the sustainable construction market within the High Performance Solutions segment.

 

 

Benoit Bazin, Chief Executive Officer of Saint-Gobain, commented:

"The acquisition of Chryso is fully in line with our strategic vision of Saint-Gobain as a world leader in sustainable construction focused on solutions offering sustainability and performance to our customers. Chryso significantly strengthens our presence on the growing construction chemicals market, where we have completed 10 acquisitions and opened 16 plants in 18 countries over the past three years, with sales today exceeding €3.0 billion in 66 countries."

 

 

Thierry Bernard, Chairman and Chief Executive Officer of Chryso, commented:

"We are delighted to be joining the Saint-Gobain Group today. The first exchanges between our teams in preparation for the integration were very enthusiastic and confirm the strong growth outlook for Chryso - particularly in regions where we are not yet present - as well as our development strategy driven by innovation and high performance solutions and the cultural proximity of our teams."

 

 

 

ABOUT SAINT-GOBAIN

Saint-Gobain designs, manufactures and distributes materials and solutions for the construction, mobility, healthcare and other industrial application markets. Developed through a continuous innovation process, they can be found everywhere in our living places and daily life, providing wellbeing, performance and safety, while addressing the challenges of sustainable construction, resource efficiency and the fight against climate change. This strategy of responsible growth is guided by the Saint-Gobain purpose, "MAKING THE WORLD A BETTER HOME", which responds to the shared ambition of all the women and men in the Group to act every day to make the world a more beautiful and sustainable place to live in.

 

€38.1 billion in sales in 2020

More than 167,000 employees, located in 70 countries

Committed to achieving Carbon Neutrality by 2050

 

For more information about Saint-Gobain,

visit www.saint-gobain.com and follow us on Twitter @saintgobain

 

 

 

Analyst/Investor relations

 

 

Press relations

Vivien Dardel

Floriana Michalowska

Christelle Gannage

 +33 1 88 54 29 77

 +33 1 88 54 19 09

 +33 1 88 54 15 49

Patricia Marie

Bénédicte Debusschere

Susanne Trabitzsch

+33 1 88 54 26 83

+33 1 88 54 14 75

+33 1 88 54 27 96

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISMZGZLNLGGMZM
Date   Source Headline
5th Sep 20088:03 amRNSIssue of Debt
24th Jul 20086:06 pmRNSInterim Results
15th Jul 200810:07 amRNSOffer Update
4th Jul 20089:08 amRNSDirectorate Change
3rd Jul 20081:29 pmRNSCancellation and De-listing
1st Jul 20087:00 amRNSOffer Update
23rd Jun 20085:19 pmRNSNew plant in India
20th Jun 20087:13 amRNSOffer Update
10th Jun 20087:00 amRNSOffer Update
6th Jun 20088:05 amRNSAcquisition
6th Jun 20088:04 amRNSAGM Statement
29th May 20084:18 pmRNSNotice of EGM
29th May 200810:16 amRNSProduct Launch
20th May 20088:01 amRNSOffer Document Posted
7th May 20084:59 pmRNSOffer for Gibbs & Dandy PLC
22nd Apr 20085:12 pmRNS1st Quarter Results
25th Mar 20087:00 amRNSRe Agreement
25th Mar 20087:00 amRNSAcquisition
25th Mar 20087:00 amRNSFinal Results
17th Mar 20087:00 amRNSAcquisition
25th Jan 20084:22 pmRNSAnnual Report and Accounts
21st Dec 20078:51 amRNSAcquisition
26th Nov 20075:12 pmRNSRe Joint Venture
8th Nov 20075:10 pmRNSAcquisition
2nd Nov 20078:49 amRNSDisposal
24th Oct 20077:00 amRNS3rd Quarter Results
7th Aug 20077:46 amRNSAcquisition
27th Jul 20075:20 pmRNSDisposal
27th Jul 20077:00 amRNSInterim Results
18th Jul 20077:30 amRNSAcquisition
17th Jul 200712:53 pmRNSDisposal
26th Apr 20075:20 pmRNS1st Quarter Results
23rd Apr 20078:23 amRNSRe Joint Venture
11th Apr 20076:01 pmRNSAcquisition
28th Mar 20078:40 amRNSIssue of Debt
23rd Mar 20076:00 pmRNSFinal Results
21st Feb 20077:46 amRNSRe Joint Venture
19th Feb 20075:43 pmRNSNew Plant
13th Feb 20078:00 amRNSAcquisition
26th Jan 20073:53 pmRNSInterim Results
21st Dec 20065:12 pmRNSAdditional Listing
3rd Nov 20068:53 amRNSIssue of Debt
24th Oct 20065:17 pmRNS3rd Quarter Results
6th Sep 20068:08 amRNSAcquisition
6th Sep 20068:05 amRNSAcquisition
28th Jul 200612:10 pmRNSInterim Results
28th Jul 200612:04 pmRNSRe Alliance
25th May 200612:28 pmRNSStabilisation Notice
25th May 200612:26 pmRNSStabilisation Notice
24th May 20063:24 pmRNSPublication of Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.